tiprankstipranks
Trending News
More News >
IGC Pharma (DE:IGS1)
FRANKFURT:IGS1
Germany Market
Advertisement

IGC Pharma (IGS1) Cash flow

Compare
6 Followers

IGC Pharma Cash Flow

DE:IGS1's free cash flow for Q2 2026 was $-2.12M. For the 2026 fiscal year, DE:IGS1's free cash flow was decreased by $437.00K and operating cash flow was $-2.09M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -4.79M$ -5.20M$ -7.05M$ -7.46M$ -10.80M
Investing Cash Flow
$ -442.00K$ -317.00K$ -235.00K$ -742.00K$ 3.39M
Financing Cash Flow
$ 4.45M$ 3.52M$ 100.00K$ 4.14M$ 14.69M
End Cash Position
$ 405.00K$ 1.20M$ 3.20M$ 10.46M$ 14.55M
Free Cash Flow
$ -5.28M$ -5.71M$ -7.67M$ -8.23M$ -12.39M
Currency in USD

IGC Pharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis